• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估广泛型银屑病或湿疹患者使用 0.05%氟替卡松乳膏对下丘脑-垂体-肾上腺轴的抑制作用。

Assessment of HPA-Axis Suppression with Fluticasone Cream 0.05% in Patients with Extensive Psoriasis or Eczema.

机构信息

Academic Dermatology Associates, Albuquerque, New Mexico, USA.

出版信息

Clin Drug Investig. 1998;16(2):111-6. doi: 10.2165/00044011-199816020-00003.

DOI:10.2165/00044011-199816020-00003
PMID:18370528
Abstract

OBJECTIVE

This study evaluated the effects of fluticasone cream 0.05% on the hypothalamopituitary-adrenal (HPA) axis in patients with extensive psoriasis or eczema.

PATIENTS

Six inpatients in a hospital setting, three with extensive eczema and three with extensive psoriasis of at least 30% body surface involvement, were enrolled in this study.

METHODS

In an open-label design, all patients received fluticasone cream 0.05%, 15g applied twice daily without occlusion for 7 consecutive days. The primary outcome measures were HPA-axis suppression (determined by morning plasma cortisol and 24-hour urinary free cortisol concentrations), selected blood chemistries, urinalysis and haematology profile.

RESULTS

During the treatment phase, four of the six patients studied experienced insignificant changes in morning plasma cortisol concentrations. In one patient, a decrease in plasma cortisol concentrations occurred following several days of treatment; these concentrations recovered after 6 to 7 days of treatment. In the remaining patient, a marked decrease in morning plasma cortisol concentrations occurred, which may have been attributed to consumption of alcohol by this patient.

CONCLUSION

Fluticasone cream 0.05% was well tolerated in patients with extensive eczema or psoriasis and had a low potential for suppressing endogenous cortisol secretion, even when applied to extensive areas of diseased skin for 7 days.

摘要

目的

本研究评估了氟替卡松乳膏 0.05% 对患有广泛银屑病或湿疹的患者下丘脑-垂体-肾上腺(HPA)轴的影响。

患者

在医院环境中纳入了 6 名住院患者,其中 3 名患有广泛湿疹,3 名患有至少 30%体表面积受累的广泛银屑病。

方法

采用开放标签设计,所有患者均接受氟替卡松乳膏 0.05%,15g 每日两次,不使用闭塞剂,连续应用 7 天。主要观察指标为 HPA 轴抑制(通过清晨血浆皮质醇和 24 小时尿游离皮质醇浓度确定)、选定的血液化学、尿液分析和血液学特征。

结果

在治疗期间,6 名研究患者中有 4 名经历了清晨血浆皮质醇浓度的无显著变化。在 1 名患者中,皮质醇浓度在治疗几天后下降;这些浓度在治疗 6 至 7 天后恢复。在其余患者中,清晨血浆皮质醇浓度明显下降,可能归因于该患者饮酒。

结论

氟替卡松乳膏 0.05% 在患有广泛湿疹或银屑病的患者中耐受性良好,即使在 7 天内应用于大面积患病皮肤,也具有低的抑制内源性皮质醇分泌的潜力。

相似文献

1
Assessment of HPA-Axis Suppression with Fluticasone Cream 0.05% in Patients with Extensive Psoriasis or Eczema.评估广泛型银屑病或湿疹患者使用 0.05%氟替卡松乳膏对下丘脑-垂体-肾上腺轴的抑制作用。
Clin Drug Investig. 1998;16(2):111-6. doi: 10.2165/00044011-199816020-00003.
2
Suppression of hypothalamic-pituitary-adrenal axis activity with inhaled flunisolide and fluticasone propionate in adult asthma patients.吸入氟尼缩松和丙酸氟替卡松对成年哮喘患者下丘脑-垂体-肾上腺轴活性的抑制作用
Ann Allergy Asthma Immunol. 2001 Nov;87(5):379-85. doi: 10.1016/S1081-1206(10)62918-3.
3
Comparison of fluticasone propionate cream, 0.05%, and hydrocortisone-17-butyrate cream, 0.1%, in the treatment of eczema.
Cutis. 1996 Feb;57(2 Suppl):51-6.
4
Effect of fluticasone propionate aqueous nasal spray versus oral prednisone on the hypothalamic-pituitary-adrenal axis.丙酸氟替卡松鼻喷雾剂与口服泼尼松对下丘脑-垂体-肾上腺轴的影响。
J Allergy Clin Immunol. 1998 Aug;102(2):191-7. doi: 10.1016/s0091-6749(98)70085-5.
5
Pharmacokinetic Profile, Safety, and Tolerability of Clascoterone (Cortexolone 17-alpha propionate, CB-03-01) Topical Cream, 1% in Subjects With Acne Vulgaris: An Open-Label Phase 2a Study.1% 丙酸皮质醇(CB-03-01)外用乳膏在寻常痤疮患者中的药代动力学特征、安全性及耐受性:一项开放标签2a期研究
J Drugs Dermatol. 2019 Jun 1;18(6):563.
6
Comparable effects of inhaled fluticasone propionate and budesonide on the HPA-axis in adult asthmatic patients.吸入丙酸氟替卡松和布地奈德对成年哮喘患者下丘脑-垂体-肾上腺轴的类似作用。
Respir Med. 2000 May;94(5):482-9. doi: 10.1053/rmed.1999.0758.
7
Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy.斑块状银屑病的局部皮质类固醇:肾上腺轴抑制和皮肤萎缩风险的系统评价。
J Eur Acad Dermatol Venereol. 2012 May;26 Suppl 3:47-51. doi: 10.1111/j.1468-3083.2012.04523.x.
8
Intranasal corticosteroids and adrenal suppression.鼻内用糖皮质激素与肾上腺抑制
Neuroimmunomodulation. 2009;16(5):353-62. doi: 10.1159/000216193. Epub 2009 Jun 29.
9
Fluticasone propionate in the treatment of inflammatory dermatoses.丙酸氟替卡松治疗炎性皮肤病
Br J Clin Pract. 1995 May-Jun;49(3):131-3.
10
Effect of calcipotriene plus betamethasone dipropionate topical suspension on the hypothalamic-pituitary-adrenal axis and calcium homeostasis in subjects with extensive psoriasis vulgaris: an open, non-controlled, 8-week trial.卡泊三醇倍他米松二丙酸酯外用混悬液对重度寻常型银屑病患者下丘脑-垂体-肾上腺轴及钙稳态的影响:一项开放、非对照的8周试验。
J Drugs Dermatol. 2013 Aug;12(8):882-7.

引用本文的文献

1
Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study.在润肤剂维持治疗基础上每周两次添加丙酸氟替卡松以降低特应性皮炎复发风险:随机、双盲、平行组研究
BMJ. 2003 Jun 21;326(7403):1367. doi: 10.1136/bmj.326.7403.1367.

本文引用的文献

1
Efficacy and safety of fluticasone propionate ointment, 0.005%, in the treatment of eczema.0.005%丙酸氟替卡松软膏治疗湿疹的疗效与安全性。
Cutis. 1996 Feb;57(2 Suppl):62-8.
2
Efficacy and safety of fluticasone propionate 0.005% ointment in the treatment of psoriasis.
Cutis. 1996 Feb;57(2 Suppl):57-61.
3
Comparison of fluticasone propionate cream, 0.05%, and hydrocortisone-17-butyrate cream, 0.1%, in the treatment of eczema.
Cutis. 1996 Feb;57(2 Suppl):51-6.
4
Comparison of safety and efficacy of fluticasone propionate cream, 0.05%, and betamethasone valerate cream, 0.1%, in the treatment of moderate-to-severe psoriasis.
Cutis. 1996 Feb;57(2 Suppl):45-50.
5
Topical corticosteroids in clinical practice: focus on fluticasone propionate.
Cutis. 1996 Feb;57(2 Suppl):4-9.
6
A comparison of the safety, tolerability, and efficacy of fluticasone propionate ointment, 0.005%, and betamethasone-17,21-dipropionate ointment, 0.05%, in the treatment of eczema.0.005%丙酸氟替卡松软膏与0.05%倍他米松-17,21-二丙酸酯软膏治疗湿疹的安全性、耐受性及疗效比较
Cutis. 1996 Feb;57(2 Suppl):32-8.
7
Comparison of fluticasone propionate ointment, 0.005%, and betamethasone-17,21-dipropionate ointment, 0.05%, in the treatment of psoriasis.
Cutis. 1996 Feb;57(2 Suppl):27-31.
8
Fluticasone propionate: safety profile.丙酸氟替卡松:安全性概况。
Cutis. 1996 Feb;57(2 Suppl):10-2.
9
The new corticosteroids: are they effective and safe?新型皮质类固醇:它们有效且安全吗?
Dermatol Clin. 1993 Jan;11(1):155-60.
10
Binding kinetics of fluticasone propionate to the human glucocorticoid receptor.丙酸氟替卡松与人糖皮质激素受体的结合动力学
Steroids. 1994 Oct;59(10):597-602. doi: 10.1016/0039-128x(94)90054-x.